検索
Sophia Genetics SA
SOPHウォッチリストに追加
6.180USD
0.0000.00%
終値 07-23 16:00（ET）15分遅れの株価
443.66M時価総額
損失額直近12ヶ月PER
詳細情報 Sophia Genetics SA 企業名
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SAの企業情報
企業コードSOPH
会社名SOPHiA GENETICS SA
上場日Jul 23, 2021
最高経営責任者「CEO」Camblong (Jurgi)
従業員数423
証券種類Ordinary Share
決算期末Jul 23
本社所在地La Piece 12
都市ROLLE
証券取引所NASDAQ OMX - NASDAQ BASIC
国Switzerland
郵便番号CH-1180
電話番号41216941060
ウェブサイトhttps://www.sophiagenetics.com/
企業コードSOPH
上場日Jul 23, 2021
最高経営責任者「CEO」Camblong (Jurgi)
Sophia Genetics SAの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.91M
-1.67%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
615.78K
-1.60%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
497.79K
-2.29%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
215.69K
-0.74%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
204.44K
+9.65%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
116.29K
-10.66%
Mr. Daan Van Well
Mr. Daan Van Well
Chief Legal and Compliance Officer
Chief Legal and Compliance Officer
--
--
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.91M
-1.67%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
615.78K
-1.60%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
497.79K
-2.29%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
215.69K
-0.74%
よくある質問
Sophia Genetics SAの上位5名の株主は誰ですか？
Sophia Genetics SAの上位5名の株主は以下のとおりです。Dr. Jurgi Camblong, Ph.D.
Sophia Genetics SA（SOPH）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Sophia Genetics SAの株式を保有している機関は89社あり、保有株式の総市場価値は約27.73Mで、全体の38.63%を占めています。2025Q4と比較して、機関の持ち株は-11894064.00増加しています。